Broader use of new MDR-TB drugs in treatment settings would bring immediate benefits to patients, Dr. KJ Seung of PIH and Dr. Cathy Hewison of MSF write in The Lancet Global Health this week.
19 snapshots of how PIH brings justice to health care around the world
Join the infectious disease expert and PIH co-founder in Sierra Leone as he mentors clinicians through their most difficult cases.
Dr. Sheila Davis, who ran PIH's Ebola response in West Africa five years ago, reflects on the progress made helping to rebuild health systems in Liberia and Sierra Leone.
Thanks to investments from the Sierra Leonean government and PIH in multidrug-resistant tuberculosis treatment, 13-year-old Cylian Kargbo survived the disease. She's become an advocate for TB patients locally.
For four children and young adults, PIH support in Koidu has meant not only better health, but also the ability to return to school and focus on bright futures.
A world-class lab in Haiti, new diagnostic and microbiology equipment, multilingual clinical trials, and carrying lab samples down mountains were among many topics at the annual workshop.
Jonathan Lascher, executive director of PIH in Sierra Leone, writes for WBUR's Cognoscenti that strong health systems are a primary factor in determining a country's response to an Ebola outbreak.
Karim Llaro finished nursing school and immediately began working for PIH in Peru, where she provided care to patients living with MDR-TB in the slums of Lima. She shares her thoughts about those early days working in global health.
Bobby Togar, 42, thought his arrival at the TB annex in Monrovia, Liberia, meant his imminent death. He'd been there before, and had little hope for survival. But this time, he found hope--and a path forward--through the clinicians he met.